BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 14600580)

  • 1. Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy.
    Floris-Moore M; Lo Y; Klein RS; Budner N; Gourevitch MN; Moskaleva G; Schoenbaum EE
    J Acquir Immune Defic Syndr; 2003 Nov; 34(3):331-7. PubMed ID: 14600580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy.
    Wolff AJ; O'Donnell AE
    Chest; 2001 Dec; 120(6):1888-93. PubMed ID: 11742918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use?
    Crum-Cianflone NF; Grandits G; Echols S; Ganesan A; Landrum M; Weintrob A; Barthel R; Agan B;
    J Acquir Immune Defic Syndr; 2010 Jul; 54(3):248-57. PubMed ID: 20658748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in New York City in the era of highly active antiretroviral therapy (HAART).
    Kim JH; Psevdos G; Gonzalez E; Singh S; Kilayko MC; Sharp V
    Infection; 2013 Apr; 41(2):545-51. PubMed ID: 23264096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
    Gona P; Van Dyke RB; Williams PL; Dankner WM; Chernoff MC; Nachman SA; Seage GR
    JAMA; 2006 Jul; 296(3):292-300. PubMed ID: 16849662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.
    Buchacz K; Baker RK; Moorman AC; Richardson JT; Wood KC; Holmberg SD; Brooks JT;
    AIDS; 2008 Jul; 22(11):1345-54. PubMed ID: 18580614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospitalization in HIV in Chicago.
    Sherer R; Pulvirenti J; Stieglitz K; Narra J; Jasek J; Green L; Moore B; Shott S; Cohen M
    J Int Assoc Physicians AIDS Care (Chic); 2002; 1(1):26-33. PubMed ID: 12942666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001.
    Betz ME; Gebo KA; Barber E; Sklar P; Fleishman JA; Reilly ED; Christopher Mathews W;
    Med Care; 2005 Sep; 43(9 Suppl):III3-14. PubMed ID: 16116304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states.
    Gebo KA; Fleishman JA; Moore RD
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):609-16. PubMed ID: 16284539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the pattern of respiratory diseases necessitating hospitalization of HIV-infected patients since the advent of highly active antiretroviral therapy.
    Dufour V; Cadranel J; Wislez M; Lavole A; Bergot E; Parrot A; Rufat P; Mayaud C
    Lung; 2004; 182(6):331-41. PubMed ID: 15765925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
    Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
    Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
    Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study.
    Hung CC; Hsiao CF; Wang JL; Chen MY; Hsieh SM; Sheng WH; Chang SC
    Int J STD AIDS; 2005 Oct; 16(10):673-6. PubMed ID: 16212714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003.
    Radhi S; Alexander T; Ukwu M; Saleh S; Morris A
    BMC Infect Dis; 2008 Sep; 8():118. PubMed ID: 18796158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy.
    Gebo KA; Diener-West M; Moore RD
    J Acquir Immune Defic Syndr; 2001 Jun; 27(2):143-52. PubMed ID: 11404536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
    Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
    Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion.
    Smit C; Geskus R; Walker S; Sabin C; Coutinho R; Porter K; Prins M;
    AIDS; 2006 Mar; 20(5):741-9. PubMed ID: 16514305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART.
    Chiappini E; Galli L; Tovo PA; Gabiano C; Lisi C; Gattinara GC; Esposito S; Viganò A; Giaquinto C; Rosso R; Guarino A; de Martino M
    AIDS; 2007 Jul; 21(12):1607-15. PubMed ID: 17630556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study.
    Kohli R; Lo Y; Homel P; Flanigan TP; Gardner LI; Howard AA; Rompalo AM; Moskaleva G; Schuman P; Schoenbaum EE;
    Clin Infect Dis; 2006 Jul; 43(1):90-8. PubMed ID: 16758423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.
    Puthanakit T; Aurpibul L; Oberdorfer P; Akarathum N; Kanjananit S; Wannarit P; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2007 Feb; 44(4):599-604. PubMed ID: 17243067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.